Clinical Trial Update: Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib with or without simvastatin in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED